SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (1289)1/28/1998 12:29:00 PM
From: george  Read Replies (1) | Respond to of 1894
 
Frank,
If DNA testing for cervical cancer works, then the Pap test is history.
However, Accumed would still be standing.....I do not think that the same would hold for automated testing......just an opinion not based on much fact.
George



To: Frank Buck who wrote (1289)1/28/1998 11:18:00 PM
From: Cisco  Read Replies (1) | Respond to of 1894
 
Frank,

If we are to expect that OncoMedics will be profitable before it burns its initial $6 million in funding from Sakura and private investors, then I guess it follows we will be seeing AcCell-Savant product before the FDA this year.

Is this your read or do you think they are planning to become profitable off the TracCell 3000 series?

Cisco


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News